| Tag | Content |
|---|
EnhancerAtlas ID | HS175-01310 |
Organism | Homo sapiens |
Tissue/cell | SK-N-MC |
Coordinate | chr1:90017570-90019270 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ELF3 | MA0640.1 | chr1:90018558-90018571 | TCACTTCCTGGTT | - | 6 | | IRF1 | MA0050.2 | chr1:90018550-90018571 | ATTTGGTTTCACTTCCTGGTT | + | 6.03 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_00486 | chr1:90017475-90024517 | Adipose_Nuclei | | SE_13864 | chr1:90017439-90019692 | CD34_Primary_RO01536 | | SE_18722 | chr1:90017773-90019030 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I089552 | chr1 | 90017833 | 90019159 |
|
Enhancer Sequence | CATTTCATTC TTATACAGAG CAGCAGTATG TCTGCTTTGT CTGCAGAGTA GCACTAATAT 60
TCAGATTTGC ATTGTGTTTG TGCAGTGTCT AATAGGGGCT ACCTGATCAC TTGCTGAAGT 120
CATAGGTAGT TCAGGAACTA CCTTCTTATT TAGATTGCTA GGACATTTTC ATAAGAATAT 180
TGTACTGTAT ATAATACTAA GCTTACTCAA ATCCTGCTTA AAATTAAAAA TAAGTATAAA 240
GAATAATAAT TAGTAAATGA GAATATATTC TGTTTTTGCA TGGTGTCTTC TAGCCCCTTC 300
TCCCACACCC AATCTCCTTG GAATAAGAGA TATGGTAATG GAGCCCAGAA ATTCATGATC 360
CTACTTAGTA TCCATCTTAG CAGAAAAATG TAAACCATAG TGAGTTTTGT TTGCTAACAC 420
TATCCTTAGA CAATAAGAAT AATCGTTAGG TACTTATAAT AACTCTCACT ATGTTTAGGT 480
TACTGAGTCA GTTAAAAGCA GACTAATCAG TAAAATACAT TTTCTGGTTT TAGAGAGCTT 540
ATAATTTACA ATAGATTAAA GGGAATGACA GTAACCACAG AAAAATAATT AAGAGAAATG 600
TGATTTACTT GTTACCTAAG AAGCAAAAGA TACATTTTTC TCCAAAGTAA GTCATTAAAG 660
ATTGCAATCG TTTATACCAG AGTTGATTTA CTAGCATGAA AATGATTGCT TAACCCTGCT 720
CCCTGTGTTC ACCAGGCGGG TTGGTGAAAG CTTGTGTTTC AGATGAGCCA GCCTGGCTAC 780
AGGAAAAGAT ATTTGCATAG AAGACTGGGG ACACTGCCAC ACAAGAAAAT GAAGAATTAT 840
GCTTTTGAAA TTCCTTTTAT TACTTCCTTG ATTAAATTGT TGTTTCCAAG GGAATTGGAT 900
TTTCAGATGA AATTTTAATA ATGCTTCAGA TAATTCCAAT TGTGTTCTTT CATTTTACTC 960
TGCTTTCACA ATATGATCAT ATTTGGTTTC ACTTCCTGGT TAGTGCACAC AAGCCTGTTG 1020
CTGGGAAATA TTTGAATAAA ATGTTTATGA GAGAAGACTA TTGTTTCAAA GTAGAGGAAG 1080
GCATTTTTGT TTGATTTAGA CTTAGTTCAT GTAGTAATTT TTATAGAAAT AAAATTTCTG 1140
ACATGTAAAT TGGTTAAAAA CACTCTTTAA AAATAATTTA AAAGACTTAT TTCGCACTGA 1200
AATTAAGTTA CCTTGTGGTG AAATCATCTC TTCTACAGAA GTGTTTGATT AGGTACCAGT 1260
TGTGCAACAA ATGAAATGTT TGTCCATAAT TAGAGTAATT GTAACTTGAT TTTAAACAGA 1320
GGTTTGATTG CATGGTGAGT GTCATAATGC CAAATGATTT TTCCATTGAT TCAGGGCCCA 1380
GTGTATTCTT AAGTTGATGT TTGATCTCAG CATGTTTAAC CTGGCCCAGA ATATATCTGG 1440
CACCCTTTTG TGTGTGTGTT GTAAATGACT GTTCTTCTGT GTTACAGCTT CATACAAAAT 1500
CTTTGCCTAT TCTAAAAGTG GTATTTTTAC CATTAAGTAT TTAATTCCAC CAGAGTACTC 1560
AGGTATTACC TAGTCTAAAA AAGTACAAAT CAAATTTATT TCTCTTTGGA AAAAGTCAGT 1620
TAAGAATTTC AGGAAACGTC TGCTTCCTTA AAATCTAATT ACTTTGTCCA TTTGCATCAG 1680
TTTACTGGCT AAATCTGAAA 1700
|
